CellCentric
VerifiedCellCentric - Epigenetics - developing small molecule inhibitors for cancer.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$165m (Public information from Sep 2023)
Company register number 04948632
Little Chesterford England (HQ)
| EUR | 2011 | 2012 | 2013 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | - | 23 % | - | 67 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | - | (1096 %) | (2186 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | - | (1095 %) | (2184 %) | - | - |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | - | - | - | 1966 % | - | - |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor investor investor | $0.0 | round |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| investor investor | $0.0 | round | |
| investor investor | $0.0 | round | |
| investor | $0.0 Valuation: $0.0 | round | |
* | $3.0m Valuation: $165m | Late VC | |
| Total Funding | 000k | ||
RELATED LANDSCAPES AND LISTS
Related Content
Recent News about CellCentric
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.